FDA approves Bayer’s Ultravist (iopromide) Injection for Contrast-enhanced Mammography
Imaging Technology
JUNE 26, 2023
The approval expands upon Bayer's focus on breast imaging, with a portfolio that also includes Gadavist (gadobutrol) injection, a gadolinium-based contrast agent approved for use with MRI ( Magnetic Resonance Imaging ) to assess the presence and extent of malignant breast disease in adult patients. for use in CEM.
Let's personalize your content